Align Technology(ALGN)

TEMPE, AZBiotechnology14 H-1B visas (FY2023)

Focus: Align Technology is a publicly traded medical device company headquartered in Tempe, AZ, specializing in clear aligner systems (Invisalign) and digital orthodontic solutions with $3.9B in FY2025 revenue. It dominates the aesthetic orthodontics market as a category leader, though it operates in the dental/orthodontic space rather than traditional pharmaceuticals.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Align Technology

AI assessmentNot Hiring

No open roles listed right now. Follow Align Technology to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Early-stage

15 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$3.9B

Pipeline & Clinical Trials

Movement Enhancement Technique

Malocclusion

N/A

Clinical Trials (1)

NCT02087163The Use of Clear Aligners With Movement Enhancement Techniques

N/A

Help build intelligence for Align Technology

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Market leader in clear aligners with $3.9B revenue and 11% YoY growth trajectory, offering exposure to a scaled, profitable business model outside traditional pharma
Strong cash generation ($445M net income in FY2025) and solid balance sheet ($1.0B cash) provide stability and investment in adjacent innovation areas including oral probiotics and dental implant solutions
Perfect H1B sponsorship record (14 approvals, 0 denials in 2023) indicates genuine visa support and diverse hiring intent for specialized talent

Watch Out For

Active European Commission antitrust investigation (July 2026) into Invisalign and intra-oral scanner conduct creates regulatory risk and potential revenue/margin pressure
Limited clinical-stage pipeline (0 Phase 1/2/3 trials; 11 total mostly device/service-based programs) means minimal exposure to traditional drug development, regulatory pathways, or novel therapeutic discovery—primarily incremental device iterations

Generated by Claude from Align Technology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Whitening

Tooth Discoloration

N/A

Clinical Trials (1)

NCT05835453At-home Bleaching Using Clear Retainers

N/A

Appliance

Orthodontic Pathological Resorption of External Root

N/A

Clinical Trials (1)

NCT02745626Comparison of Oral Hygiene & Root Resorption During Orthodontic Treatment

N/A

Invisalign® System with mandibular advancement featuring occlusal blocks

Class II Malocclusion

N/A

Clinical Trials (1)

NCT06651944Invisalign® System with Mandibular Advancement

N/A

Invisalign

Malocclusion

N/A

Clinical Trials (3)

NCT06662279Hyrax Vs. Invisalign Palatal Expander Clinical Study

N/A

NCT02376829Class II Correction Study Using the Invisalign System

N/A

NCT02603289One Week Aligner Evaluation

N/A

Invisalign 7-day wear protocol

Orthodontic Tooth Movement

N/A

Clinical Trials (1)

NCT05905224Clinical Trial to Assess the Efficacy of Reducing the Aligners' Wear Protocol

N/A

Invisalign

Malocclusion

N/A

Clinical Trials (1)

NCT02550938Primer Aligner Study

N/A

Treatment of implant single crown

Dental Implant

N/A

Clinical Trials (1)

NCT05165563Treatment Time Comparing Digital & Conventional Workflows

N/A

Invisalign System

Malocclusion

N/A

Invisalign System with Mandibular Advancement

Class II Malocclusion

N/A

Oral Probiotics

Halitosis

N/A

Clinical Trials (1)

NCT05651503The Effect of Oral Probiotics on Oral Hygiene and Halitosis in Orthodontic Patients.

N/A

Palatal Expander

Malocclusions

N/A

At-home Teeth Whitening

Tooth Discoloration

N/A

Dental Implant Crown Treatment

Dental Implant

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2014

Portfolio: 11 clinical trials

H-1B (2023): 14 approvals

Publications: 18 in PubMed

SEC Filings: 2 available

Financials (FY2025)

Revenue

$3.9B3%

R&D Spend

$347M(9%)14%

Net Income

$445M

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Four-dimensional (4D) virtual simulation for predicting soft tissue support and vertical dimension of occlusion in full-arch implant therapy - A proof of concept.

Journal of dentistry

2025

PMID:41061915

The "Sashette" attachment for correcting severely rotated upper central incisors.